ACM
BSX icon

Absolute Capital Management’s Boston Scientific BSX Stock Holding History

Absolute Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,028
Closed -$670K – 149
2025
Q4 		$670K Buy
+7,028
New +$689K 0.24% 84

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Absolute Capital Management's BSX Position: Q1 2026 in Review

Absolute Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 7,028 shares — an estimated $670K sold.

Absolute Capital Management first reported a position in BSX in Q4 2025 and held it in 1 quarter. The position peaked at $670K in Q4 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Absolute Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Absolute Capital Management sold 7,028 Boston Scientific shares in Q1 2026, an estimated $670K.
  • Absolute Capital Management first reported a position in Boston Scientific in Q4 2025 and held it in 1 quarter.
  • Absolute Capital Management's Boston Scientific position peaked at $670K in Q4 2025.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Absolute Capital Management's 13F filing for Q1 2026, filed 12 May 2026.